Insider Buy/Sell Details for the Healthcare Sector — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1586)
PTC THERAPEUTICS, INC. (PTCT)
Pauwels Eric — CHIEF BUSINESS OFFICER
Shares
3,019
Price
$69.36
Total Value
$209.40K
Shares Held After
77,122
% of Holdings
3.8%
Septerna, Inc. (SEPN)
Bhatt Elizabeth — President and COO
Shares
1,800
Price
$29.58
Total Value
$53.25K
Shares Held After
174,209
% of Holdings
1.0%
Septerna, Inc. (SEPN)
Bhatt Elizabeth — President and COO
Shares
2,200
Price
$28.46
Total Value
$62.61K
Shares Held After
176,009
% of Holdings
1.2%
PTC THERAPEUTICS, INC. (PTCT)
Klein Matthew B. — Director
Shares
7,371
Price
$69.36
Total Value
$511.25K
Shares Held After
387,082
% of Holdings
1.9%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
65
Price
$69.36
Total Value
$4.51K
Shares Held After
6,726
% of Holdings
1.0%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
3,056
Price
$69.36
Total Value
$211.96K
Shares Held After
112,140
% of Holdings
2.7%
Lexeo Therapeutics, Inc. (LXEO)
Otero Jose Manuel — Chief Operating Officer
Shares
3,016
Price
$6.40
Total Value
$19.29K
Shares Held After
125,460
% of Holdings
2.3%
Annexon, Inc. (ANNX)
Overdorf Michael — EVP & CHIEF BUSINESS OFFICER
Shares
6,225
Price
$5.10
Total Value
$31.75K
Shares Held After
124,464
% of Holdings
4.8%
Lexeo Therapeutics, Inc. (LXEO)
Townsend Richard Nolan — Director
Shares
10,173
Price
$6.38
Total Value
$64.92K
Shares Held After
392,483
% of Holdings
2.5%
PTC THERAPEUTICS, INC. (PTCT)
Utter Christine Marie — SVP, CHIEF ACCOUNTING OFFICER
Shares
2,494
Price
$69.36
Total Value
$172.98K
Shares Held After
70,199
% of Holdings
3.4%
Annexon, Inc. (ANNX)
ARTIS DEAN RICHARD — EVP & CHIEF SCIENTIFIC OFFICER
Shares
5,290
Price
$5.10
Total Value
$26.98K
Shares Held After
123,487
% of Holdings
4.1%
HEALTHCARE SERVICES GROUP INC (HCSG)
Orr Patrick J — EVP & Chief Revenue Officer
Shares
33,448
Price
$20.52
Total Value
$686.35K
Shares Held After
0
% of Holdings
100.0%
HEALTHCARE SERVICES GROUP INC (HCSG)
Orr Patrick J — EVP & Chief Revenue Officer
Shares
11,167
Price
$20.55
Total Value
$229.48K
Shares Held After
33,448
% of Holdings
25.0%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Militello John — See Remarks
Shares
1,157
Price
$3.34
Total Value
$3.86K
Shares Held After
91,019
% of Holdings
1.3%
Annexon, Inc. (ANNX)
Lew Jennifer — EVP & CHIEF FINANCIAL OFFICER
Shares
7,851
Price
$5.11
Total Value
$40.12K
Shares Held After
113,765
% of Holdings
6.5%
Annexon, Inc. (ANNX)
Yednock Ted — EVP & CHIEF INNOVATION OFFICER
Shares
7,857
Price
$5.11
Total Value
$40.15K
Shares Held After
97,227
% of Holdings
7.5%
ALX ONCOLOGY HOLDINGS INC (ALXO)
Pinto Shelly — SVP, FINANCE AND CAO
Shares
565
Price
$2.27
Total Value
$1.28K
Shares Held After
87,708
% of Holdings
0.6%
Keros Therapeutics, Inc. (KROS)
Regnante Keith — CHIEF FINANCIAL OFFICER
Shares
4,739
Price
$16.35
Total Value
$77.48K
Shares Held After
39,261
% of Holdings
10.8%
Annexon, Inc. (ANNX)
Dananberg Jamie — CHIEF MEDICAL OFFICER
Shares
5,290
Price
$5.10
Total Value
$26.98K
Shares Held After
73,152
% of Holdings
6.7%
Voyager Therapeutics, Inc. (VYGR)
Swartz Robin — COO & CBO
Shares
3,882
Price
$3.44
Total Value
$13.35K
Shares Held After
206,196
% of Holdings
1.8%
Keros Therapeutics, Inc. (KROS)
Lerner Lorena Raquel — Chief Science Officer
Shares
3,873
Price
$16.35
Total Value
$63.32K
Shares Held After
31,127
% of Holdings
11.1%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Wilson Martin — General Counsel
Shares
1,376
Price
$3.34
Total Value
$4.59K
Shares Held After
682,000
% of Holdings
0.2%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Shah Gaurav — CEO
Shares
5,990
Price
$3.34
Total Value
$19.99K
Shares Held After
1,046,055
% of Holdings
0.6%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
1,276
Price
$79.97
Total Value
$102.04K
Shares Held After
0
% of Holdings
100.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
3,026
Price
$79.16
Total Value
$239.53K
Shares Held After
1,276
% of Holdings
70.3%
Voyager Therapeutics, Inc. (VYGR)
Carter Todd Alfred — Chief Scientific Officer
Shares
3,301
Price
$3.44
Total Value
$11.36K
Shares Held After
149,892
% of Holdings
2.2%
ACCURAY INC (ARAY)
MAYER STEVEN F — Director
Shares
126,125
Price
$0.53
Total Value
$67.20K
Shares Held After
1,421,745
% of Holdings
8.9%
Cencora, Inc. (COR)
Mauch Robert P. — Director
Shares
1,333
Price
$359.46
Total Value
$479.16K
Shares Held After
65,393
% of Holdings
2.0%
Keros Therapeutics, Inc. (KROS)
Cho Esther — SVP, General Counsel
Shares
4,745
Price
$16.35
Total Value
$77.58K
Shares Held After
39,755
% of Holdings
10.7%
Voyager Therapeutics, Inc. (VYGR)
Sandrock Alfred — Director
Shares
11,732
Price
$3.41
Total Value
$40.01K
Shares Held After
498,257
% of Holdings
2.3%
Aveanna Healthcare Holdings, Inc. (AVAH)
Shaner Jeff — Chief Executive Officer
Shares
168,800
Price
$7.38
Total Value
$1.25M
Shares Held After
2,824,117
% of Holdings
5.6%
Aveanna Healthcare Holdings, Inc. (AVAH)
Buckhalter Matthew — Chief Financial Officer
Shares
13,167
Price
$7.38
Total Value
$97.21K
Shares Held After
542,755
% of Holdings
2.4%
Aveanna Healthcare Holdings, Inc. (AVAH)
Cunningham Patrick A. — Chief Compliance Officer
Shares
17,965
Price
$7.38
Total Value
$132.63K
Shares Held After
356,191
% of Holdings
4.8%
Aveanna Healthcare Holdings, Inc. (AVAH)
Stewart Deborah — SVP, Chief Accounting Officer
Shares
10,896
Price
$7.38
Total Value
$80.44K
Shares Held After
312,988
% of Holdings
3.4%
Aveanna Healthcare Holdings, Inc. (AVAH)
Reisz Edwin C. — Chief Administrative Officer
Shares
59,217
Price
$7.38
Total Value
$437.19K
Shares Held After
1,507,826
% of Holdings
3.8%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
Farmer Michele — See Remarks
Shares
14,952
Price
$1.63
Total Value
$24.36K
Shares Held After
219,092
% of Holdings
6.4%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
Van Oene Mark — See Remarks
Shares
55,107
Price
$1.63
Total Value
$89.77K
Shares Held After
1,742,638
% of Holdings
3.1%
HEALTHCARE SERVICES GROUP INC (HCSG)
Orr Patrick J — EVP & Chief Revenue Officer
Shares
45,500
Price
$20.54
Total Value
$934.57K
Shares Held After
44,615
% of Holdings
50.5%
HEALTHCARE SERVICES GROUP INC (HCSG)
SHEA JOHN CHRISTOPHER — EVP & Chief Admin. Officer
Shares
38,857
Price
$20.36
Total Value
$791.13K
Shares Held After
29,292
% of Holdings
57.0%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
HENRY CHRISTIAN O — See Remarks
Shares
140,874
Price
$1.63
Total Value
$229.48K
Shares Held After
2,673,500
% of Holdings
5.0%
HEALTHCARE SERVICES GROUP INC (HCSG)
SHEA JOHN CHRISTOPHER — EVP & Chief Admin. Officer
Shares
15,500
Price
$20.52
Total Value
$318.06K
Shares Held After
29,292
% of Holdings
34.6%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Taylor Ben R — Chief Financial Officer
Shares
13,426
Price
$3.08
Total Value
$41.35K
Shares Held After
1,195,349
% of Holdings
1.1%
KalVista Pharmaceuticals, Inc. (KALV)
Yea Christopher — CHIEF DEVELOPMENT OFFICER
Shares
1,109
Price
$15.00
Total Value
$16.64K
Shares Held After
224,173
% of Holdings
0.5%
KalVista Pharmaceuticals, Inc. (KALV)
Audhya Paul K. — CHIEF MEDICAL OFFICER
Shares
1,163
Price
$15.00
Total Value
$17.45K
Shares Held After
133,087
% of Holdings
0.9%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
1,038
Price
$15.00
Total Value
$15.57K
Shares Held After
429,667
% of Holdings
0.2%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
2,100
Price
$29.80
Total Value
$62.57K
Shares Held After
20,729
% of Holdings
9.2%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
2,983
Price
$29.04
Total Value
$86.64K
Shares Held After
22,829
% of Holdings
11.6%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
2,281
Price
$29.80
Total Value
$67.97K
Shares Held After
556,247
% of Holdings
0.4%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
3,552
Price
$29.05
Total Value
$103.19K
Shares Held After
558,528
% of Holdings
0.6%
EXELIXIS, INC. (EXEL)
Smith Julie — Director
Shares
20,030
Price
$44.30
Total Value
$887.33K
Shares Held After
20,590
% of Holdings
49.3%
Showing 551–600 of 1586 transactions (page 12 of 32)